Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 28, 2017; 23(32): 5969-5976
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5969
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5969
Figure 1 Outcomes of hepatitis C virus RNA (A), alanine amino transferase levels (B) and estimated glomerular filtration rates (C) at different treatment time points in the six patients.
EOT: End of therapy; ALT: Alanine aminotransferase; eGFR: Estimated glomerular filtration rate; HCV: Hepatitis C virus.
- Citation: Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976
- URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5969.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5969